EUVIMEDEUVIMED entdecken
Crossref

Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience

Ehsan Mahmoodi iD, Xiang Wen Lee, Blake M Freeman, Meghan A Webster, John R Betts, Haris M Haqqani, Russell A Denman

Internal Medicine Journal · 2025

DOI: 10.1111/imj.70014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Ehsan Mahmoodi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Prince Charles Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Heart Failure, Death, Sudden, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) has become an established alternative to overcome conventional transvenous ICD (TV‐ICD) lead‐related complications.

Aims

To describe the long‐term outcomes of S‐ICD implantation at a single Australian institution.

Methods

We retrospectively reviewed the clinical outcomes of consecutive patients who underwent S‐ICD implantation from 2015 to 2019.

Results

In total, 128 patients (median age 52.5 years, 70% male) underwent S‐ICD implantation. The indication was primary prevention in 86 patients (66%), and 22 patients (17%) had a previous transvenous device. Seventy‐seven patients (60%) had heart failure, and the median left ventricular ejection fraction was 36% (29%–60%). The procedure was performed under general anaesthesia in 124 patients (97%), and the median procedure time was 105 min (interquartile range (IQR) 90–120). During a median follow‐up of 4.7 years (IQR 3.8–5.8), 15 patients (12%) died, none of which were due to sudden death or device‐related complications. Inappropriate shocks occurred in 17 patients (13.3%), predominantly due to T‐wave oversensing (4.7%) and supraventricular arrhythmias (4.7%), and 15 patients (11.7%) received appropriate shocks. During the follow‐up period, the S‐ICD system was revised to TV‐ICD in 10 patients (8%), and 24 patients (19%) required S‐ICD generator change. Four patients (3%) underwent surgical intervention due to lead (two) or pocket‐related (two) complications, and two patients (1.5%) developed pocket infection without systemic sepsis.

Conclusion

In this single‐centre study, S‐ICDs were implanted safely with acceptable device performance and clinical outcomes over long‐term follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableHeart FailureDeath, Sudden, CardiacHumansMaleFemaleMiddle AgedRetrospective StudiesAustraliaTreatment OutcomeAdultAgedFollow-Up Studies

Stichwörter der Autor:innen

appropriate shockinappropriate shocksubcutaneous implantable cardioverter‐defibrillator

Autor:innen und Institutionen

  • Department of Cardiology, The Prince Charles Hospital, Brisbane, Queensland, Australia.
  • Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Ehsan Mahmoodi

Zitieren

APA

Mahmoodi, E., Lee, X. W., Freeman, B. M., Webster, M. A., Betts, J. R., Haqqani, H. M., & Denman, R. A. (2025). Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience. Internal Medicine Journal. https://doi.org/10.1111/imj.70014

Vancouver

Mahmoodi E, Lee XW, Freeman BM, Webster MA, Betts JR, Haqqani HM, et al. Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience. Internal Medicine Journal. 2025. doi:10.1111/imj.70014

BibTeX
@article{Mahmoodi2025,
  author = {Mahmoodi, Ehsan and Lee, Xiang Wen and Freeman, Blake M and Webster, Meghan A and Betts, John R and Haqqani, Haris M and Denman, Russell A},
  title = {Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience},
  journal = {Internal Medicine Journal},
  year = {2025},
  doi = {10.1111/imj.70014}
}
Kostenlos starten →